XML 32 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue      
Healthcare services income $ 431,378 $ 1,295,889 $ 1,541,778
Operating expenses      
Cost of healthcare services (420,812) (1,215,824) (1,459,924)
Research and development expenses (5,198,329) (9,219,595) (10,869,642)
General and administrative fees (1,930,637) (5,220,405) (5,409,302)
Legal and professional fees (2,538,161) (2,888,140) (2,617,834)
Other operating expenses (1,067,690) (261,038) (392,511)
Total operating expenses (11,155,629) (18,805,002) (20,749,213)
Other income (expenses), net      
Loss on investments in marketable securities, net (9,266) (134,134) (8,031,595)
Unrealized gain from fair value change of the long-term investments, net 6,353,888 5,588,051
Loss on investments in derivatives (4,289)
Gain on use of digital currencies 4,918
Gain on derecognition of non-financial assets 75,000
Interest (expense) income, net (121,145) 146,588 (93,601)
Loss on disposal of subsidiaries (3,638)
Sundry income 159,799 383,506 146,347
Total other income (expenses), net 6,383,276 5,984,011 (7,906,858)
Net loss (4,340,975) (11,525,102) (27,114,293)
Net loss attributable to non-controlling interests 1,516,328 1,725,542 2,065,904
Net loss attributable to Aptorum Group Limited $ (2,824,647) $ (9,799,560) $ (25,048,389)
Net loss per share attributable to Aptorum Group Limited      
- Basic (in Dollars per share) [1] $ (0.62) $ (2.75) $ (7.15)
- Diluted (in Dollars per share) [1] $ (0.62) $ (2.75) $ (7.15)
Weighted-average shares outstanding      
- Basic (in Shares) [1] 4,521,133 3,569,484 3,503,396
- Diluted (in Shares) [1] 4,521,133 3,569,484 3,503,396
Net loss $ (4,340,975) $ (11,525,102) $ (27,114,293)
Other comprehensive (loss) income      
Exchange differences on translation of foreign operations (44,430) 35,826 (55,315)
Other comprehensive (loss) income (44,430) 35,826 (55,315)
Comprehensive loss (4,385,405) (11,489,276) (27,169,608)
Comprehensive loss attributable to non-controlling interests 1,516,328 1,725,542 2,065,904
Comprehensive loss attributable to the shareholders of Aptorum Group Limited $ (2,869,077) $ (9,763,734) $ (25,103,704)
[1] All per share amounts and shares outstanding for all periods have been retroactively restated to reflect APTORUM GROUP LIMITED’s 1 for 10 reverse stock split, which was effective on January 23, 2023.